Dystrophic bladder wall calcifications following intravesical BCG treatment for superficial transitional cell carcinoma of bladder. 1993

J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
Department of Radiology, Brooke Army Medical Center, Fort Sam Houston, Texas.

Bacillus Calmette-Guerin has been established as one of the most active agents for the treatment of superficial transitional cell carcinoma of the bladder. Although complications do occur with this agent, they are usually transient and mild. Two cases are herein reported in which dystrophic calcification of the urinary bladder occurred following BCG therapy; one had a diffuse and severe complication. This complication can occur with other intravesical agents, and methods for management are reported.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001745 Urinary Bladder Diseases Pathological processes of the URINARY BLADDER. Bladder Diseases,Bladder Disease,Urinary Bladder Disease
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
April 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
November 2021, BMJ case reports,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
July 1993, Urology,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
April 2007, The Canadian journal of urology,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
November 1989, Urology,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
January 2016, Clinical medicine insights. Case reports,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
January 1991, Urology,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
June 1996, Urology,
J P Spirnak, and W L Lubke, and I M Thompson, and M Lopez
September 1998, Current opinion in urology,
Copied contents to your clipboard!